Abstract
submission is now open for the next EACPT Congress, to be held in Geneva
28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications
Symposium on Methodological issues in clinical trials with CNS drugs
Clinical trials
provide the basis for the acquisition of the critical information that
physicians need for rational prescribing. Therefore, clinical trials should be
designed and conducted utilizing clinically meaningful procedures and endpoints
and potential bias should be minimized.
Methodological issues
in clinical trials of central nervous system (CNS) drugs include aspects
related to study design, procedures of randomization, inclusion and exclusion
criteria, treatment outcome measures, sample size, statistical power and
ethical considerations.
In this respect, the
use of placebo arms in randomized controlled trials remains a very
controversial problem when evaluating the efficacy and safety of medications
used to treat neurological or psychiatric disorders. This symposium focuses
mainly on the shortcomings of clinical trials in epilepsy, neuropathic pain and
schizophrenia.
Over 900 participants are expected to attend including
health professionals, scientists, policy makers, biotechnology and
pharmaceutical professionals and others with an interest
in basic and clinical pharmacology, pharmacotherapy,
drug discovery and development, regulatory affairs and related
areas.See here for more on key themes of the Congress.
EACPT Geneva 2013 Congress website www.eacpt2013.org
No comments:
Post a Comment